High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV

Bone Marrow Transplantation
N M Butt, R E Clark

Abstract

Cytomegalovirus (CMV) causes significant morbidity and mortality following allogeneic haemopoietic stem cell transplantation. A pre-emptive strategy for ganciclovir therapy is widely used, where treatment is commenced on finding positive evidence of CMV replication. Surveillance by PCR has increased the sensitivity for CMV detection, but it is not known whether this may detect cases with evidence of CMV DNAemia who have a low probability of CMV disease. We reviewed our experience of CMV infection and disease since introducing CMV surveillance by PCR. All 30 allografts received bedside leucodepleted CMV-negative blood products. Seven of 10 CMV-positive recipients of a CMV-positive graft developed CMV DNAemia, with three developing clinical disease requiring ganciclovir treatment. In contrast, of 11 low risk patients (CMV-negative recipients of CMV-negative grafts), six developed evidence of CMV DNAemia although only one had clinical evidence of CMV disease requiring ganciclovir. Transfusion records confirmed that four of these had received exclusively CMV-negative blood products. The aetiology of the CMV DNAemia in these cases is unclear. It is suggested that before commencing ganciclovir therapy, confirmatory CMV antigenaemia t...Continue Reading

References

Oct 1, 1991·British Journal of Haematology·S IshigakiY Niitsu
Mar 1, 1986·The Journal of Infectious Diseases·J D MeyersE D Thomas
Feb 1, 1993·Annals of Internal Medicine·J M GoodrichJ D Meyers
Jan 1, 1996·Intervirology·J Sinclair, P Sissons
Aug 15, 1998·Journal of Clinical Microbiology·C Y TongA Bakran
Jun 3, 1999·Transfusion Medicine·D H PamphilonL M Williamson

❮ Previous
Next ❯

Citations

May 5, 2009·Enfermedades infecciosas y microbiología clínica·Julián Torre-CisnerosAntonio Torres
Sep 20, 2018·Annual Review of Psychology·Richard E Mayer
Feb 4, 2021·Infectious Agents and Cancer·Mehrdad PayandehMohammad Dehghannejad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.